Asklepios Kliniken

Phase II study of bortezomib, cyclophosphamide and dexamethasone as induction therapy in multiple myeloma: DSMM XI trial (2017) Einsele H, Engelhardt M, Tapprich C, Mueller J, Liebisch P, Langer C, Kropff M, et al. Journal article Anaesthesiological managemnet at paediatric cardiac surgical centres in Germany: Current status of personnel and structural organisation Anästhesiologische Versorgung an deutschen Zentren für Kinderherzchirurgie: Aktueller Stand der personellen und strukturellen Organisation (2016) Bähner T, Heinze I, Mueller M, Schindler E, Schirmer U, Hoeft A, Baumgarten G, et al. Journal article Emotionsbezogene Techniken in der Psychotherapie (2016) Lammers CH Journal article Sensitivity and Specificity of Autoantibodies Against CD74 in Early Axial Spondyloarthritis (2016) Witte T, Riechers E, Baerlecken NT, Baraliakos X, Bakhsh KAM, Aries P, Bannert B, et al. Conference contribution INTER SPA: SENSITIVITY AND SPECIFITY OF AUTOANTIBODIES AGAINST CD74 IN EARLY AXIAL SPONDYLOARTHRITIS (2016) Riechers E, Baerlecken NT, Baraliakos X, Bakhsh KAM, Aries PM, Bannert B, Becker K, et al. Conference contribution ANTI-MODIFIED PROTEIN ANTIBODY RESPONSE PATTERN INFLUENCES THE RISK FOR DISEASE RELAPSE IN RHEUMATOID ARTHRITIS PATIENTS TAPERING DISEASE MODIFYING ANTI-RHEUMATIC DRUGS (2016) Figueiredo C, Bang H, Cobra JF, Englbrecht M, Hueber AJ, Haschka J, Manger B, et al. Conference contribution EFFECTS OF DMARD TAPERING ON TREATMENT COSTS IN RHEUMATOID ARTHRITIS PATIENTS-AN ANALYSIS FROM THE PROSPECTIVE RANDOMIZED CONTROLLED RETROSTUDY (2016) Hagen M, Figueiredo C, Cobra JF, Reiser M, Haschka J, Englbrecht M, Hueber A, et al. Conference contribution A new novolimus-eluting bioresorbable scaffold for large coronary arteries: an OCT study of acute mechanical performance (2016) Boeder NF, Koepp T, Dorr O, Bauer T, Mattesini A, Elsasser A, Mollmann H, et al. Journal article Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment (2016) Rech J, Hueber A, Finzel S, Englbrecht M, Haschka J, Manger B, Kleyer A, et al. Journal article Randomized, Double-Blind, Phase III Trial of Enzastaurin Versus Placebo in Patients Achieving Remission After First-Line Therapy for High-Risk Diffuse Large B-Cell Lymphoma (2016) Crump M, Leppa S, Fayad L, Lee JJ, Di Rocco A, Ogura M, Hagberg H, et al. Journal article